Literature DB >> 18654647

Addressing hemolysis in an infant due to mother-infant ABO blood incompatibility.

Sandra Martin1, Rebecca N Jerome, Marcia I Epelbaum, Annette M Williams, William Walsh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18654647      PMCID： PMC2479049          DOI： 10.3163/1536-5050.96.3.002

Source DB:  PubMed          Journal:  J Med Libr Assoc        ISSN： 1536-5050


× No keyword cloud information.
  16 in total

Review 1.  Systematic review of intravenous immunoglobulin in haemolytic disease of the newborn.

Authors:  R Gottstein; R W I Cooke
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2003-01       Impact factor: 5.747

2.  Respiratory regulation in the newborn.

Authors:  M STAHLMAN
Journal:  Ann N Y Acad Sci       Date:  1963-06-24       Impact factor: 5.691

3.  Celebrating individual heroes: the continuing relevance of Estelle Brodman.

Authors:  Judith Messerle
Journal:  J Med Libr Assoc       Date:  2008-07

4.  Intravenous immune globulin in neonatal immune hemolytic disease: does it reduce hemolysis?

Authors:  C Hammerman; H J Vreman; M Kaplan; D K Stevenson
Journal:  Acta Paediatr       Date:  1996-11       Impact factor: 2.299

5.  Multiple dose IVIG treatment in neonatal immune hemolytic jaundice.

Authors:  G Tanyer; Z Siklar; Y Dallar; Y Yildirmak; U Tiraş
Journal:  J Trop Pediatr       Date:  2001-02       Impact factor: 1.165

6.  Evidence based medicine: what it is and what it isn't.

Authors:  D L Sackett; W M Rosenberg; J A Gray; R B Haynes; W S Richardson
Journal:  BMJ       Date:  1996-01-13

7.  High-dose intravenous immunoglobulin therapy in neonatal immune haemolytic jaundice.

Authors:  F Alpay; S U Sarici; V Okutan; G Erdem; O Ozcan; E Gökçay
Journal:  Acta Paediatr       Date:  1999-02       Impact factor: 2.299

8.  High-dose intravenous gammaglobulin therapy for neonatal immune haemolytic jaundice due to blood group incompatibility.

Authors:  K Sato; T Hara; T Kondo; H Iwao; S Honda; K Ueda
Journal:  Acta Paediatr Scand       Date:  1991-02

9.  Intravenous immunoglobulin therapy in neonatal immune hemolytic jaundice.

Authors:  Z Ergaz; I Arad
Journal:  J Perinat Med       Date:  1993       Impact factor: 1.901

10.  Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation.

Authors: 
Journal:  Pediatrics       Date:  2004-07       Impact factor: 7.124
View more
  1 in total

1.  CD144+ endothelial microparticles as a marker of endothelial injury in neonatal ABO blood group incompatibility.

Authors:  Hisham A E Awad; Azza A G Tantawy; Rania A El-Farrash; Eman A Ismail; Noha M Youssif
Journal:  Blood Transfus       Date:  2013-11-15       Impact factor: 3.443
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.